 GAITHERSBURG, Md. and SHANGHAI, Dec. 4, 2020 PRNewswire -- Cellular Biomedicine Group Inc. NASDAQ: CBMG CBMG or the Company, a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, announced today... 